SINGAPORE, Nov. 14, 2025 — Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“Phaos” or “the Company”), the investment holding company for Phaos Technology Pte. Ltd., an advanced microscopy solutions provider, announced today the successful closure of its previously declared initial public offering. This Offering involved the sale of a total of 2,700,000 class A ordinary shares of the Company (the “Offering”) at a price of US$4.00 per share (the “Offering Price”) to the public, generating gross proceeds of US$10,800,000 for the Company, prior to underwriting discounts and other associated expenses. In addition, under the Offering, certain existing shareholders of the Company sold a total of 900,090 class A ordinary shares at the Offering Price. The Company did not receive any proceeds from these sales by the selling shareholders.
The Company’s class A ordinary shares commenced trading on the NYSE American on November 13, 2025, under the ticker symbol “POAS”. The Company has granted the underwriter a 45-day option to acquire an additional 405,000 class A ordinary shares at the Offering Price, less underwriting discounts, solely to cover any over-allotments. This represents 15% of the class A ordinary shares sold by the Company in the Offering (excluding shares sold by selling shareholders and those subject to this over-allotment option). Should the over-allotment option be fully exercised, the Company anticipates receiving approximately US$12,420,000 in gross proceeds, before deducting underwriting discounts and other offering expenses.
Network 1 Financial Securities, Inc. (“Network 1”), a comprehensive broker/dealer, served as the sole book-running manager for the Offering. Ortoli Rosenstadt LLP acted as U.S. securities legal counsel to the Company, while Loeb & Loeb LLP provided U.S. counsel for Network 1 in connection with the Offering.
The Offering was conducted in accordance with the Company’s registration statement on Form F-1 (File No. 333-284137), which was previously filed with the U.S. Securities and Exchange Commission (“SEC”) and became effective on November 11, 2025 (the “Effective Date”). This effectiveness was in compliance with Section 8(a) of the U.S. Securities Act of 1933, as amended, as stated affirmatively on the cover of the final post-effective registration statement on Form F-1. Notice of this post-effective registration statement was filed on October 22, 2025, twenty days before the Effective Date. The Offering was made exclusively through a prospectus, forming part of the Form F-1 registration statement. A final prospectus for the Offering was filed with the SEC on November 13, 2025, and is accessible on the SEC’s website at www.sec.gov. Electronic copies of the final prospectus related to the Offering can be obtained, when available, by visiting EDGAR on the SEC Website. Alternatively, electronic copies may be requested from Network 1 at 2 Bridge Avenue, Suite 241 Red Bank, NJ 07701, or by calling +1 (732) 758-9001.
Prior to making an investment, prospective investors should carefully review the prospectus and any other documents the Company has filed or intends to file with the SEC for detailed information about the Company and the Offering. This press release is intended strictly for informational purposes and should not be construed as an offer to sell or a solicitation of an offer to purchase these securities. Furthermore, these securities may not be offered or sold in the United States without registration or an applicable exemption from registration, nor shall any offer, solicitation, or sale of these securities occur in any state or jurisdiction where such actions would be illegal without prior registration or qualification under local securities laws.
About Phaos Technology Holdings (Cayman) Limited
Phaos Technology Holdings (Cayman) Limited is a company at the forefront of advanced microscopy technology. We are dedicated to innovation and excellence, striving to deliver cutting-edge microscopy products and software solutions, enhanced by artificial intelligence, to various sectors including manufacturing, biomedical, and research. Discover the distinct advantage of Phaos Technology – where pioneering innovation meets refined sophistication, shaping the trajectory of optical technology. For additional details, please visit .
FORWARD-LOOKING STATEMENTS
Certain declarations within this announcement constitute forward-looking statements, including, but not limited to, the Company’s proposed Offering. These forward-looking statements encompass known and unknown risks and uncertainties, and they are predicated on the Company’s present expectations and projections regarding future events that the Company believes could influence its financial condition, operational outcomes, business strategy, and funding requirements, including the expectation that the Offering will successfully conclude. Investors can identify many (though not all) of these statements through the use of terms such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “likely to,” or other comparable expressions. The Company assumes no obligation to publicly update or revise any forward-looking statements to reflect subsequent events, changing circumstances, or alterations in its expectations, except as mandated by law. While the Company believes that the expectations conveyed in these forward-looking statements are reasonable, it cannot guarantee that such expectations will prove accurate. The Company advises investors that actual results may differ substantially from the anticipated results and encourages investors to examine other factors that could impact its future performance as detailed in the Company’s registration statement and other filings with the SEC.
Contacts
Company Contact:
Phaos Technology Holdings (Cayman) Limited
Telephone: (65) 6250 3877
Underwriter Inquiries:
Network 1 Financial Securities, Inc.
Adam Pasholk
2 Bridge Avenue, Suite 241
Red Bank, NJ 07701
Phone: +1 (732) 758-9001
Email:
Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email:
